Demographic and pre-procedural information
| Characteristic | N | Percent |
|---|---|---|
| Total cases | 472 | |
| Gender | ||
| Male | 236 | 50 |
| Female | 236 | 50 |
| Age | ||
| Mean±SD | 70±16 | |
| Anticoagulation status | ||
| Warfarin | 59 | 12.5 |
| Mean INR±SD (n=55) | 1.6±0.5 | |
| Rivaroxaban | 1 | 0.2 |
| No prior anticoagulation | 412 | 87.3 |
| Patients with INR>1.7 | 28 | 5.9 |
| Dual Antiplatelet therapy | 10 | 2.1 |
| Thrombolytic therapy | ||
| IA tPA | 103 | 21.8 |
| IV tPA | 123 | 26.1 |
| IV and IA tPA | 34 | 7.2 |
| No tPA | 212 | 44.9 |
IA, intra-arterial; tPA, tissue Plasminogen Activator.